Oct 2026· Pediatric Research· 0 citations· 54 references
Medicine
TL;DR
Bundle-based quality-improvement packages were associated with lower neonatal VAP rates, although heterogeneous bundle composition and non-randomized designs limit causal interpretation, and oral care was also associated with lower VAP odds.
Abstract
Background
To assess preventive strategies for ventilator-associated pneumonia (VAP) in mechanically ventilated (MV) neonates.
Methods
PubMed, Embase, Web of Science, and Cochrane Library were searched in June 2025. Eligible studies evaluated primary VAP-prevention interventions in neonates receiving MV. Outcomes included odds ratios (ORs), incidence rate ratios (IRRs), and incidence rate differences (IRDs).
Results
Thirty-four studies involving 6,301 neonates were included. Bundle-based quality-improvement packages were associated with lower VAP occurrence (OR = 0.40, 95% CI 0.28-0.57; I² = 37%). MV-adjusted analyses showed lower incidence (IRR = 0.56, 95% CI 0.43-0.73) and 8.33 fewer VAP cases per 1000 MV-days (IRD = -0.0083, 95% CI -0.0127 to -0.0039). Oral care was associated with lower VAP odds (OR = 0.53, 95% CI 0.35-0.81; I² = 3%). Evidence for other interventions was limited and heterogeneous.
Conclusions
Bundle-based quality-improvement packages were associated with lower neonatal VAP rates, although heterogeneous bundle composition and non-randomized designs limit causal interpretation. Oral care was also associated with lower VAP odds, but confidence in the magnitude of effect is limited by small-study effects, inconsistent subgroup findings, and variable diagnostic criteria.
IMPACT
This study provides the most comprehensive synthesis to date focused exclusively on VAP in ventilated neonates, incorporating ventilator-day-adjusted outcomes. By using robust meta-analytic methods across diverse study designs, it clarifies which interventions have consistent evidence and which remain uncertain. Bundle-based quality-improvement packages were associated with meaningful relative and absolute reductions in neonatal VAP. The findings support further evaluation and implementation of bundle-based quality-improvement strategies. Uncertainty regarding the magnitude of benefit from oral care and the need for higher-quality controlled studies.
Subgroup analysis revealed that among mechanically ventilated infants, the infection rate was substantially higher among preterm infants, and this finding underscores high VAP incidence among mechanically ventilated neonates, which poses a significant challenge to clinical management.
Fei-Fei Wu, Jie Wang, Zhong-Hua Li et al.· Paediatric Respiratory Revie...· 0 citations
Ventilator care bundles are used to prevent ventilator-associated pneumonia (VAP), but differences in outcome denominators and study design complicate interpretation. We examined patient-level VAP risk and ventilator-time incidence density separately.
PubMed/MEDLINE, Embase, CENTRAL, and Web of Science were...
Min-Fang Qian, Yan Lan· Frontiers in Medicine· 0 citations
Background: Ventilator-Associated Pneumonia (VAP) is a major healthcare associated infection among patients with artificial airway management and burden of VAP varies among ICUs in India. This systematic review focuses on VAP occurring between the years 2015 to 2025 in India. Reported studies are expected to include da...
S. Patil, Sameer Chandratre· International Journal of Adv...· 0 citations
Introduction. Ventilator-associated pneumonia (VAP) remains one of the most common and critical complications in patients receiving artificial lung ventilation (ALV) in intensive care units (ICUs). It is characterized by high morbidity, increased hospital stay and mortality. Assessing the epidemiological risk is an imp...
A. M. Muhametzjanov, T. V. Kajdanek, D. A. Kuzina· Medicina· 0 citations
Prevention of Ventilator-associated pneumonia requires a multimodal approach that integrates organizational support with evidence-based preventive measures and consistent adherence to multidisciplinary prevention bundles remains fundamental for reducing the burden of VAP.
E. Tsigou, G. Papathanakos, Elena Conoscenti et al.· Intensive & Critical Care Nu...· 0 citations
Abstract Background Ventilator-associated pneumonia (VAP) is a major healthcare-associated infection (HAI) in intensive care units (ICUs), with a high burden in low- and middle-income countries (LMICs). Despite WHO-recommended prevention bundles, adherence remains low, leading to preventable infections and antimicrobia...
T. Sedrakyan, A. Stepanyan, H. Ghazaryan et al.· European Journal of Public H...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.